Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure
Status:
Completed
Trial end date:
2014-10-21
Target enrollment:
Participant gender:
Summary
The objective of this study is to conduct a population pharmacokinetic analysis of
caspofungin in a population of patients with moderate and severe acute alcoholic hepatitis or
liver disease with Child-Pugh score B and C in order to better characterize pharmacokinetic
parameters in case of moderate and severe liver dysfunction.